Q Code

ALL CODES   A CODE   B CODE   C CODE   CPT CODE   J CODE   NOC CODE   P CODE   Q CODE   S CODE  COST

DRONABINOL – Q0167

DRONABINOL is an Oncology-Anti-Emetic drug manufactured by Ascend Laboratories and administered via the Oral route of administration. The Q Code: Q0167 is aligned to the drug DRONABINOL.

Read More »

Ondansetron – Q0162

Ondansetron is an Oncology-Anti-Emetic drug manufactured by A-S Medication Solutions and administered via the Oral route of administration. The Q Code: Q0162 is aligned to the drug Ondansetron.

Read More »

CARVYKTI – Q2056

CARVYKTI is an Oncology drug manufactured by Janssen and administered via the Intravenous route of administration. The Q Code: Q2056 is aligned to the drug CARVYKTI.

Read More »

AVONEX – Q3027

AVONEX is a Neurology drug manufactured by Biogen and administered via the Intramuscular route of administration. The Q Code: Q3027 is aligned to the drug AVONEX.

Read More »

REBIF – Q3028

REBIF is a Neurology drug manufactured by EMD Serono and administered via the Subcutaneous route of administration. The Q Code: Q3028 is aligned to the drug REBIF.

Read More »

VENTAVIS – Q4074

VENTAVIS is a Cardiology drug manufactured by Actelion and administered via the Inhalation route of administration. The Q Code: Q4074 is aligned to the drug VENTAVIS.

Read More »

OGIVRI – Q5114

OGIVRI is an Oncology Biosimilar drug manufactured by Mylan and administered via the Intravenous route of administration. The Q Code: Q5114 is aligned to the drug OGIVRI.

Read More »

Trazimera – Q5116

Trazimera is an Oncology Biosimilar drug manufactured by Pfizer and administered via the Intravenous route of administration. The Q Code: Q5116 is aligned to the drug Trazimera.

Read More »

TRUXIMA – Q5115

TRUXIMA is an Oncology Biosimilar drug manufactured by Cephalon and administered via the Intravenous route of administration. The Q Code: Q5115 is aligned to the drug TRUXIMA.

Read More »